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ABSTRACT: Label-free plasmonic biosensors have demonstrated promising capabilities as analytical tools for the detection of 
virtually any type of biomarker. They are presented as good candidates for precision diagnostics since they offer highly sensitive, 
cost-effective solutions that can be used in any clinical or laboratory setting without the need for specialized trainees. However, 
different surface functionalization protocols are required depending on the nature of the biorecognition element, limiting their capa-
bilities for integrated multibiomarker detection. Here, we present a simple, yet efficient one-step immobilization approach that is 
common for both DNA probes and antibodies. Our immobilization approach relies on the incorporation of polyA blocks in both 
nucleic acid probes and antibodies, which specifically interact with the gold surface with sufficient strength to generate dense and 
highly ordered monolayers. We have demonstrated excellent performance of our universal functionalization method, showing limits 
of detection and quantification in the pM-nM range. Moreover, it was able to reduce up to 50% the background signal from undilut-
ed serum samples compared to conventional methods, demonstrating the immense potential of this strategy for the direct analysis of 
human biofluids, essential for rapid point-of-care diagnostics. The polyA-based immobilization approach is a promising alternative 
for the biofunctionalization of microarray-format sensors and their application to multiplexed diagnostic assays. 
Precision diagnostics is a growing field seeking to transform 
healthcare by providing comprehensive, insightful and accu-
rate clinical information of patients.1 Its implementation can 
foster individualized disease management and, ultimately, 
improve the patient outcome and quality of life. To meet these 
requirements, there is a need to deploy advanced tools that can 
inform about the patient molecular fingerprint, including var-
iations in their genome, epigenome, transcriptome, proteome 
and metabolome, which will allow to relate them with a con-
crete disease. Ideally, these tools should afford multimarker 
detection with ultra-high sensitivity and specificity to shed 
light about the interplay between different biomarkers of di-
verse nature and recognize specific patterns that can inform 
about tailored treatments.2 
Biosensors are analytical devices that can employ multiple 
biorecognition elements, such as antibodies or DNA probes, 
for the specific detection of target analytes in a sample, such 
as proteins, nucleic acids, small molecules or even whole cells, 
like viruses or bacteria.3 Optical biosensors explore the inter-
action of the analyte with electromagnetic fields and have 
given rise to some of the most sensitive, robust, and versatile 
analytical devices. Particularly, plasmonic and nanoplasmonic 
biosensors are nowadays positioned at the forefront of optical 
technologies for the achievement of new powerful devices 
with potential applications not only in clinical diagnostics, 
biomedical and pharmacological studies, but also in food safe-
ty, and environmental monitoring.3 The landmark of optical 
biosensors is the Surface Plasmon Resonance (SPR) system. 
SPR biosensors are based on the excitation of the so-called 
surface plasmon polaritons, which are coherent oscillations of 
conductive electrons at the surface of a nanometer-thick layer 
of certain metals, being gold the most widely employed. These 
plasmons generate an evanescent field at the metal surface that 
penetrates and exponentially decays into the surrounding die-
lectric medium reaching a few hundreds of nanometers (100-
500 nm). A change of mass or composition of the dielectric 
within the evanescent field produces a change of the refractive 
index (RI) that will be, in turn, transduced into a change in the 
light properties, such as intensity, wavelength, or phase. This 
sensing principle therefore enables the direct quantification of 
specific analytes as a one-step assay, without need of labelling 
and in real time.4 
The label-free analysis capability of plasmonic biosensors is 
certainly one of their best assets, but it also implies certain 
limitations. The overall analytical sensitivity and specificity of 
these systems ultimately depend on the sensor surface biofunc-
tionalization. An optimum immobilization of the biorecogni-
tion elements on the gold layer must ensure their correct orien-
tation, optimal coverage density and high stability, and pro-
vide antifouling properties that prevent the non-specific bind-
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ing of non-relevant molecules. The latter is especially im-
portant when dealing with complex biological samples, like 
blood serum or plasma, since the adsorption of matrix compo-
nents onto the sensor surface can lead to false-positive signals. 
Over the last years, a myriad of sensor biofunctionalization 
strategies have been described.2,5 In the case of antibodies, as 
the most widely used biorecognition element, a common ap-
proach is the covalent binding to a self-assembled monolayer 
(SAM) of functional alkanethiol molecules through the amine-
terminal residues.6 This well-known methodology provides a 
robust biomolecule attachment and certain coverage of the 
remaining gold surface. However, the antibodies are immobi-
lized in random orientation, so hindering part of the antigen 
binding sites (Fab regions). In order to control antibody orien-
tation, one can make use of affinity ligands such as the pro-
teins A or G that bind to the Fc region of antibodies, or the 
biotin-avidin pair, when the antibody is biotinylated through 
the carbohydrate Fc chains.7–9 Other strategies propose anti-
body fragmentation via disulfide bond reduction for direct 
chemisorption of the resultant thiols (-SH), or the immobiliza-
tion of only Fab chains.10 All these stepwise methodologies 
are usually employed in immunosensor development and have 
demonstrated undeniable advantages over simple, direct but 
low reproducible physical adsorption of the antibodies. How-
ever, it is critical to perform, in each case, an in-depth optimi-
zation of every procedure step to select the correct SAM com-
position, activation times, concentration of affinity ligands, the 
antibody-tag conjugation, or fragmentation reaction times. In 
the case of DNA, the possibility of obtaining synthetic probes 
of high purity containing the desired sequence and including 
an end-terminal functional group, greatly facilitates the surface 
biofunctionalization.11 For gold surfaces, the most common 
and simple strategy is to use the DNA oligonucleotide se-
quence with a thiol (-SH) group for direct chemisorption on 
gold. To control the DNA probe density and minimize steric 
hindrance effects, it is frequent to include alkanethiol mole-
cules as lateral spacers, or to immobilize the DNA strand onto 
a SAM, similarly to antibody immobilization.2 Likewise, all 
these surface chemistry strategies must be carefully studied 
and optimized during biosensor development to achieve the 
best analytical performance. 
The major challenge is found on the road of technology 
transfer and implementation of these biosensors in the clinical 
field. The implementation of different biofunctionalization 
protocols involving different steps for both, protein and DNA 
biomarker detection, can be complex and cumbersome, limit-
ing the capabilities of plasmonic biosensors. Ideally, the sen-
sor biofunctionalization should be an easy and direct proce-
dure that can be automated, highly reproducible, and ensuring 
maximum bioreceptor activity. In this work, we propose a 
surface biofunctionalization approach for gold-based sensors 
that enables one-step and rapid immobilization of antibodies 
and DNA probes in an oriented manner, with controlled densi-
ty and distribution, and antifouling properties. Our strategy 
relies on the preferential and remarkably high affinity of ade-
nine (A) for gold, and the dramatic relative difference with 
thymine (T) (Figure 1A). Indeed, DNA nucleotides affinities 
for gold follow the order A > G ≈ C >> T.12 It has been shown 
that strands of polyAm-polyTn attach to gold surfaces adopting 
an L-shaped conformation, where the polyA tail binds com-
pletely flat to the surface while the polyT chain extends away 
from the surface, vertically oriented.13,14 Contrary to what 
might be expected, the hairpin conformation of self-
complementary polyAm-polyTn oligonucleotides in solution is 
disrupted in presence of gold, resulting in close-saturation 
coverage of the metal sensor surface by the polyA blocks.14 
We have incorporated the polyAm-polyTn tails to both DNA 
probes and antibodies and optimized the methodology for the 
direct and label-free detection of clinically relevant bi-
omarkers (Figure 1B). By varying the polyA length, it is pos-
sible to deterministically control the probe density and distri-
bution, while the polyT block provides the upright orientation. 
We have studied the analytical performance of our approach 
for SPR biosensing, comparing it with other traditional bio-
functionalization strategies, evaluating the antifouling proper-
ties for the analysis of clinical samples (i.e., blood serum), and 
exploring the capabilities for sensor surface regeneration and 
reusability. Our versatile polyA approach is compatible with 
conventional laboratory procedures, so it could be implement-
ed in the research and industrial production lines of antibodies 
and DNA probes, even including other protein receptors, en-
zymes, and aptamers.15–17 Also, it could be applied for other 
gold-based sensor and biosensor technologies, such as nano-
plasmonic arrays or colloidal nanoparticles, electrochemical or 
piezoelectric sensors, among others. 
Figure 1. PolyA immobilization strategy. (A) Scheme of the pro-
posed mechanism for adenine adsorption on gold surfaces: major 
interaction is attributed to coordination to the metal by the N at-
oms of the amine group and the N7 atom. (B) DNA probe and 
antibody immobilized on the gold sensor surface in an L-shape 
conformation. 
EXPERIMENTAL DETAILS 
Chemical and Biological Reagents and Buffers. The list 
of chemical and biological reagents, buffers and solvents used 
in this work is provided in the Supporting Information. 
SPR Biosensor. The SPR studies have been performed by 
the ICTS “NANBIOSIS”, more specifically at the Unit of Bi-
odeposition and Biodetection (U4) of CIBER in Bioengineer-
ing, Biomaterials & Nanomedicine (CIBER-BBN) at ICN2 
facilities. The SPR biosensor device is based on the Kretsch-
mann configuration and monitors RI changes in real time. A p-
polarized light of 670 nm from a laser source is divided in two 
identical beams focused on the backside of the gold sensor 
chip (glass surface coated with 1.5 nm of titanium and 48 nm 
of gold, 10×10×0.3 mm3, SSens, Enschede, The Netherlands). 
Measurements are performed at a fixed angle of incidence. 
Variations of the RI due to the biointeraction events occurring 
at the sensor surface are detected as changes in the reflected 
light intensity by a multielement photodiode. The flow system 
consists of two flow cells (300 nL each) for independent anal-
ysis. The device incorporates all optical, electronic and fluidic 
components necessary to operate autonomously. Sensorgrams 
reproduce the binding events by monitoring the increase (or 
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decrease in case of unbinding events) of the intensity of the 
reflected light (ΔReflectivity (%), ΔR (%)) vs. time (seconds, 
s). This change in the intensity of the reflected light is directly 
related to changes in the RI of the dielectric medium caused 
by mass changes on the metallic sensor surface. 
PolyA-DNA probes immobilization. Formation of mono-
layers of polyA-DNA probes was carried in situ at 1 μM con-
centration in CaCl2-TE buffer. Different polyAm block lengths 
were employed, where m is the number of adenine nucleotides 
(m = 7, 15), i.e. PolyA7 and PolyA15. Several combinations of 
the probes presenting the two different block lengths at differ-
ent molar ratios (i.e polyA7/polyA15 = 1:0, 0:1, 1:1, 1:2 and 
2:1) were tested. H2O-DEPC was selected as running buffer 
for the immobilization procedure at a constant rate of 12 
µL/min, approximately. Conventional immobilization strate-
gies (thiol chemisorption and amine covalent coupling) are 
described in the Supporting Information. 
DNA hybridization and biosensor regeneration. Samples 
containing Fas567 target sequence were injected into the bio-
sensor at a 15 μL/min rate. Hybridization with their comple-
mentary DNA probes immobilized on the gold sensor surface 
was monitored in real-time by a custom-made LabVIEW 
Software. These samples were dissolved in the hybridization 
buffer (5× SSC -0.45 M NaCl, 0.045 M sodium citrate- with 
45% formamide). Target-probe interactions were disrupted by 
using 50% formamide in aqueous solution. A calibration curve 
was obtained for polyA-DNA probe by triplicate measure-
ments of Fas567 at different concentrations (2.5, 5, 10, 20, 30, 
and 50 nM). The mean and the standard deviation (SD) of 
each concentration were plotted versus the target concentra-
tion and fitted to a saturation binding model. Limit of Detec-
tion (LOD) was calculated as the concentration corresponding 
to the blank signal plus three times its SD, while the Limit of 
Quantification (LOQ) was determined as the concentration 
corresponding to the minimum measurable signal, set as the 
blank plus 10 times SD. 
PolyA-Antibody conjugation and immobilization. Mono-
clonal anti-CRP antibodies (Ab) were conjugated to NH2-
polyT26-polyA15 oligonucleotides via amine coupling (random 
orientation) and via aldehyde coupling (controlled orienta-
tion). For random conjugation we used bis(sulfosuccinimidyl) 
suberate (BS3) crosslinker. Antibodies (1 mg/mL) were dilut-
ed in 10 mM PBS pH 7.5 and mixed with BS3 at 20-fold mo-
lar concentration. Reaction mixture was incubated at room 
temperature (RT) for 30 minutes and quenched with 50 mM 
Tris buffer and purified using 30K centrifugal filter units 
(Amicon Ultra, Merck Life Science S.L.U., Spain). BS3-
modified antibodies were mixed with the polyA tail (1:2 
Ab/oligonucleotide) and incubated for 2 h at RT in gentle agi-
tation. The mixture was finally purified with 30K centrifugal 
filter units and buffer was changed to 10 mM PBS. For con-
trolled orientation conjugation (see Figure S3 in the Support-
ing Information for the general scheme), anti-CRP antibodies 
(1 mg/mL) were first oxidized by incubation with 10 mM 
NaIO4 in acetate buffer for 30 min at RT in dark conditions. 
Then, the antibodies were purified using 30K centrifugal filter 
units and buffer was switched to 100 mM bicarbonate buffer 
pH 6.0. In parallel, oligonucleotide modification with succin-
imidyl-6-hydrazino-nicotinamide (s-HyNic) crosslinker was 
carried out following supplier instructions: 1 mM oligonucleo-
tide was dissolved in 100 mM bicarbonate buffer pH 8.0, and 
200 mM s-HyNic was dissolved in anhydrous dimethylfor-
mamide (DMF). 20 molar equivalents of s-HyNic solution 
were added to the oligonucleotide solution, keeping the DMF 
percentage below 5%. The mixture was incubated for 1.5 h at 
RT, purified using 3K centrifugal filter units and desalted to 
100 mM bicarbonate buffer pH 6.0. For conjugation, both 
solutions were mixed (1:2 Ab/oligonucleotide) and aniline 
(100 mM) was added as catalyst. The mixture was incubated 
with gentle agitation for 2 h, at RT, purified using 30K cen-
trifugal filter units, and buffer was switched to 10 mM PBS. 
Characterization was carried out by spectroscopic determina-
tion using a UV Cary 4000 spectrometer measuring absorb-
ance at λ=354 nm. The final concentration of the polyA-Ab 
conjugates was also determined by measuring absorbance of 
antibodies at λ=280 nm. Immobilization of the polyA-Ab con-
jugates was carried out in flow by injecting a 50 μg/mL solu-
tion diluted in CaCl2-TE buffer at 15 μL/min. Conventional 
immobilization strategies (i.e physical adsorption and covalent 
coupling) are described in the Supporting Information. 
Protein detection and biosensor regeneration. CRP pro-
tein samples in PBS were flowed over the biofunctionalized 
sensor surface at 15 μL/min flow rate and the response was 
monitored in real time. After each sample, regeneration of the 
surface was achieved by injecting HCl 5 mM at 50 μL/min. 
Calibration curves were obtained by triplicate measurements 
of CRP at different concentrations (50 - 2000 ng/mL). The 
mean and the standard deviation (SD) of each concentration 
were plotted versus the target concentration and fitted to a 
saturation binding model. Limit of Detection (LOD) was cal-
culated as the concentration corresponding to the blank signal 
plus three times its SD, while the Limit of Quantification 
(LOQ) was determined as the concentration corresponding to 
the minimum measurable signal, set as the blank plus 10 times 
SD. 
Antifouling evaluation. The fouling effect was assessed for 
different monolayers of DNA (polyA-DNA, chemisorbed SH-
DNA, covalently attached NH2-DNA over a MHDA/MUOH 
SAM) and antibodies monolayers (polyA-Ab, Ab physical 
adsorption, covalently attached Ab over a MHDA/MUOH 
SAM). 250 µL of 100% commercial Human Serum (Sigma-
Aldrich, Steinhem, Germany) samples were flowed at a 15 
μL/min rate over the sensor surface. After that, serum was 
washed away by PBS running buffer. Shifts in the SPR sensor 
response baseline were measured to determine the background 
signal generated in each monolayer by the non-specific contact 
of the different components of the serum sample. 
RESULTS 
Our investigation on polyA-based sensor biofunctionaliza-
tion approach for multimarker detection have included four 
main aspects: the design and preparation of polyA-conjugated 
DNA probes and antibodies, the study on the sensitivity and 
specificity of this strategy for direct and label-free detection of 
clinically relevant nucleic acid and protein biomarkers, the 
evaluation of the stability, reproducibility and reusability of 
the biosensor, and the antifouling properties for human bioflu-
id analysis. 
Design and preparation of polyA-conjugated DNA 
probes. The length of the homonucleotide polyA tail deter-
mines both the immobilization stability and the bioreceptor 
density and distribution. Likewise, the polyT block serves as 
vertical spacer to ensure the upright orientation and enough 
distance to the surface for efficient capture of the target ana-
lyte. In previous works, polyA15 tails were pointed to provide 
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the best coverage and stability for DNA immobilization, and 
they were combined with additional polyAk spacers to control 
the density and target accessibility.14 However, the hybridiza-
tion yields notably decreased in all cases when introducing 
polyAk spacers with different lengths (i.e. k = 7, 15 or 25) and 
at increasing concentrations of these spacers. The introduction 
of polyA spacers effectively reduces the probe density at the 
expense of reducing the target binding capacity as well. In 
order to avoid dramatic changes in probe density and have a 
better probe density control, instead of using polyA sequences 
as spacers, we have designed two DNA probes including two 
different lengths of polyAm tails (m being 7 or 15). We hy-
pothesize that, if we combine probes with different polyA 
lengths, we can fine-tune more precisely the probe density 
and, therefore, increase the accessibility of the target without 
compromising the number of probes available at the gold sen-
sor surface. Each probe includes a polyT15 sequence to pro-
mote the upright conformation of the probes in an L-shaped 
conformation (Table S1).14  
Biosensing performance of polyA-immobilized DNA 
probes. To demonstrate our biofunctionalization approach, we 
have selected Fas gene 567 mRNA as a model. Fas gene is 
involved in critical cell regulation and apoptotic pathways and 
has been demonstrated to be a good biomarker for early cancer 
diagnosis. Our previous work showed the excellent analytical 
performance of an SPR biosensor specific for this biomarker 
using SH-DNA probes.18,19 Thus, we will use it as a reference 
to compare with the polyA strategy. In addition, we also ex-
plored the analytical performance of DNA monolayers gener-
ated with MHDA/MUOH alkanethiols (for functionalization 
methods see Supporting Information). To study the analytical 
behavior of polyA-DNA probes, we monitored the immobili-
zation process in real-time via in situ immobilization (i.e by 
tracking the SPR reflectance intensity shift in %ΔR during the 
probe injection). Several parameters were optimized to ensure 
a proper surface coverage and to provide a good probe density 
for an adequate accessibility of the target while minimizing 
non-specific adsorptions. CaCl2-TE buffer was employed for 
polyA grafting on the gold sensor chip, since it rendered the 
best immobilization signal (see Fig. S1). In addition, we com-
pared the one-step poly-A immobilization strategy perfor-
mance with the conventional thiol-chemistry based methodol-
ogy and with the MHDA/MUOH monolayer. For that, we 
employed 1 µM of polyA-DNA, SH-DNA and NH2-DNA 
probes respectively. As can be appreciated in Figure S2, im-
mobilization of polyA-DNA probes provided a high sensor 
response, which was comparable to that obtained with SH-
DNA probes. NH2-DNA probes produced a lower sensor re-
sponse, which could be explained by the low density of car-
boxylic groups available on the SAM monolayer. Next, to 
obtain the maximum hybridization yield, we evaluated the 
hybridization performances with the two selected polyAm 
block lengths, i.e. polyA7 and polyA15. Likewise, we tested 
combination of the probes with the two block lengths at differ-
ent polyA7/polyA15 molar ratios (1:0, 0:1, 1:1, 1:2 and 2:1). 
All tested ratio provided similar immobilization signals, 
demonstrating that the immobilization efficiency was the same 
regardless of the length of the polyA block or their configura-
tion (data not shown). We employed synthetic DNA sequences 
homologous to Fas567 mRNA (Table S1). Figure 2A shows 
a set of SPR measurements that quantitatively examines the 
effect in the hybridization efficiency of the two different pol-
yA probes employed, either alone or co-immobilized at differ-
ent ratios. Longer polyAm blocks (m = 15) led to higher SPR 
responses, demonstrating a better accessibility of the targets. 
However, the intensity of the signal was largely improved by 
using a mix of the two polyA lengths, achieving the most suit-
able conditions at a 2:1 molar proportion of polyA7/polyA15. 
These results confirm our hypothesis that a combination of 
different polyA tail lengths help controlling the density and 
accessibility of DNA probes on the gold surface in a more 
accurate and precise way, which may allow to further improve 
the biosensor performance. 
For a close comparison of the analytical performance of the 
2:1 polyA-DNA monolayer with the SH-DNA and NH2-DNA 
approaches, we obtained a calibration curve by measuring 
different concentrations of Fas567 in triplicate, ranging from 0 
to 50 nM, diluted in the hybridization buffer (5x SSC + 45% 
FA). As can be seen in Figure 2B, increasing concentrations 
of Fas567 led to increasing SPR sensor responses. As a con-
trol, we employed a synthetic Fas57 DNA sequence, which is 
the DNA homologous sequence of Fas57 mRNA (Table S1). 
Fas57 mRNA is generated from the same Fas mRNA precur-
sor by a process called alternative splicing. This Fas isoform 
shares half of its sequence with Fas567 mRNA and, therefore, 
can be prone to cross-hybridization with our polyA-based 
Fas567 probe. As can be observed in Figure 2B, Fas57 gen-
erated negligible SPR response at different concentrations 
(from 5 to 50 nM), proving the specificity of our biosensor 
towards Fas567. To compare the polyA-DNA sensor perfor-
mance, we calculated different analytical figures of merit, 
including limit of detection (LOD), and limit of quantification 
(LOQ). Using the polyA-DNA monolayer, the sensor achieved 
a LOD of 557 pM and a LOQ of 1.9 nM. These results are 
very comparable with the ones obtained with the SH-DNA 
monolayer (LOD of 863 pM and a LOQ of 3 nM) and the 
MHDA/MUOH monolayer (LOD of 698 pM and a LOQ of 
2.5 nM) using the same detection conditions. These results 
demonstrate that, although polyA blocks do not attach cova-
lently to the gold sensor surface, it can render analogue bio-
sensor performance to the conventional widely-used ap-
proaches, suggesting it as a good alternative for the generation 
of DNA monolayers. 
Preparation of polyA-conjugated antibodies. Unlike 
DNA probes, which can be synthesized with the desired se-
quence and functional reactive groups, antibodies are biologi-
cally produced, therefore they must be conjugated to tags af-
terwards employing chemical crosslinkers. Conjugation of 
polyA tails to antibodies was carried out in two ways: via 
amine-terminal groups of the Lys present in the entire struc-
ture, which and leads to a random antibody orientation; and 
via carbohydrate side chains, for an end-on antibody orienta-
tion. In order to increase the flexibility and movement of the 
antibodies, and to ensure enough vertical and lateral spacing, 
we considered only the longer polyA sequence with 15 nu-
cleotides and a longer polyT sequence of 26 nucleotides (pol-
yT26) according to previous studies.
20 In both cases, amine-
functional polyA oligonucleotide strands were employed 
(NH2-polyT26-polyA15), following standard conjugation proce-
dures described elsewhere (Figure S3).21,22 For non-oriented 
polyA-Ab conjugation we employed a homobifunctional 
amine crosslinker: bis(sulfosuccinimidyl)suberate (BS3). This 
crosslinker contains a N-hydroxysuccinimide (NHS) ester at 
each end, separated by an 8-carbon chain. The NHS ester read-
ily reacts with terminal NH2 groups of lateral lysine chains, 
which are randomly distributed and available in antibodies. 
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The other NHS ester binds the NH2-polyT26-polyA15 tail. This 
procedure is well-established and provide high conjugation 
yields, but it may result in chemical modification of the anti-
gen binding sites (Fab regions) of antibodies therefore reduc-
ing their binding capability.21,23 For oriented polyA-Ab conju-
gation, we took advantage of the carbohydrate moieties mainly 
expressed on the Fc region of antibodies. The strategy essen-
tially consists in creating active aldehyde (CHO) groups by 
mild oxidation of the cis-diols of carbohydrates. The CHO 
groups are highly reactive and can directly bind primary 
amines. However, direct binding of primary amines to activat-
ed aldehyde groups leads to weak and unstable bonds; instead, 
the terminal amine group of hydrazides is strongly nucleo-
philic and spontaneously reacts with aldehydes to form stable 
hydrazone bonds.24 
To achieve that, we employed a heterobifunctional cross-
linker: succinimidyl-6-hydrazino-nicotinamide (s-HyNic), that 
reacts with primary amines of the polyA oligonucleotide via 
NHS ester and introduces a reactive hydrazine group for the 
binding to the CHO-activated antibodies.22 With this proce-
dure, the polyA tail is linked exclusively to the constant region 
of antibodies, which would be immobilized in an end-on con-
figuration, leaving the antigen binding sites free and available 
for analyte detection. The conjugation reaction was traced and 
quantified by UV-spectrometry of the bis-arylhydrazone 
groups, which exhibits a characteristic absorbance peak at 354 
nm (Figure S3). Determination of the absorbance in the result-
ing conjugate allows calculating the molar substitution ratio 
(MSR), set as the relative concentration of the bis-
arylhydrazone group per total antibody concentration. We 
obtained a MSR of 1.84, which means a total yield of the reac-
tion of approximately 75%. The applied procedure renders in a 
highly efficient polyA-Ab conjugation, and the resulting anti-
bodies in solution were ready to be directly immobilized onto 
gold sensor surfaces. 
Biosensing performance of polyA-immobilized antibod-
ies. To assess the performance of polyA-Ab immobilization 
approach we selected the C-reactive protein (CRP) as a target 
biomarker model. This protein is a reference clinical bi-
omarker for the detection of inflammatory procedures, such as 
infections, cardiac disorders, or some solid cancers (ref). Of-
ten, the quantification of CRP alone does not provide accurate 
diagnosis information, but it should be included in biomarker 
panels in combination with other proteins and nucleic acids to 
identify the origin of the disease. We compared the immobili-
zation and detection efficiencies of the polyA approach with 
common antibody biofunctionalization procedures: physical 
adsorption and covalent binding to an alkanethiol SAM 
(MHDA/MUOH 1:20).9 Further, we evaluated both oriented 
and non-oriented conjugation strategies in terms of assay sen-
sitivity. Figure 3A shows the antibody immobilization signals 
(at 50 μg/mL) obtained with the SPR biosensor for the differ-
ent biofunctionalization strategies. As expected, polyA-Ab 
conjugates produced similar responses than physical adsorp-
tion of antibodies onto the gold surface, which indicates a high 
coverage of the sensor. Covalent binding of antibodies to an 
alkanethiol SAM via carbodiimide chemistry renders lower 
antibody coverage, probably due to lower chemical reaction 
yields. But to accurately evaluate different biofunctionaliza-
tion strategies, it is necessary to compare the detection per-
formance in terms of sensitivity and specificity. We obtained 
standard calibration curves for the direct detection of CRP 
over a wide range of concentrations (50 - 2000 ng/mL) with 
anti-CRP antibodies immobilized through the four different 
strategies (Figure 3B). Besides, we confirmed the detection 
specificity with negative control proteins (BSA). The best 
analytical performance in terms of sensitivity and detectability 
was obtained with the oriented polyA-Ab immobilization, with 
a LOD around 2 ng/mL, and LOQ around 50 ng/mL. Non-
oriented immobilizations either with polyA tail or via covalent 
binding showed similar results in terms of detectability (LOD 
non-oriented polyA = 11 ng/mL; LOD covalent binding = 7 
ng/mL) and quantification (LOQ non-oriented polyA = 36 
ng/mL; LOQ covalent binding = 72 ng/mL), although the non-
oriented polyA-Ab had a larger dynamic range, associated 
with the higher density of antibodies immobilized. On the 
contrary, physical adsorption strategy showed the poorest effi-
ciency, with a LOD of 72 ng/mL, a LOQ of 258 ng/mL, and a 
very prompt saturation at relatively low biomarker concentra-
tions. This can be explained by possible antibody denaturation 
in direct contact with the gold surface and absolute no-control 
of the orientation that hinder antigen binding, despite of the 
high surface coverage. These results demonstrate that the pol-
yA-based biofunctionalization strategy is highly advantageous 
for antibody immobilization since it enables end-on orienta-
tion control as well as providing certain mobility to the anti-
bodies, therefore maximizing the antigen binding capacity. 
 
Figure 2. PolyA-DNA probe assay. (A) Hybridization signals of 
Fas567 in different polyA7/polyA15 DNA-probe molar ratios. (B) 
Fas567 calibration curve for polyA-DNA monolayer, SH-DNA 
monolayer and MHDA/MUOH NH2-DNA monolayer. Solid line 
corresponds to the non-linear fit of the calibration curves. All data 
show mean ± SD of triplicate measurements 
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Figure 3. PolyA-Antibody assay. (A) Immobilization signals for 
the different approaches studied. (B) CRP calibration curves for 
each immobilization approach. Solid lines correspond to the non-
linear fit of the calibration curves. All data show mean ± SD of 
triplicate measurements. 
Stability and reusability of the polyA biosensor surface. 
The polyA-based sensor biofunctionalization is based on elec-
trostatic interactions that do not involve chemical linkage as in 
the case of thiol chemisorption or covalent binding to a SAM. 
Therefore, it is important to study and evaluate the stability, 
reproducibility, and reusability of the biosensor when using 
this approach. Regeneration of the biorecognition layer, i.e. 
releasing of the captured target biomarker, was tested for both 
DNA and antibodies taking into account the possibility to per-
form repeated detection cycles with the same efficiency and 
sensitivity. Nucleic acid regeneration was achieved with 50% 
formamide solution, which disrupts hybridization at RT.2 Re-
peated measurements were performed over 25 hybridiza-
tion/regeneration cycles with signal variations of less than 3%. 
On the other hand, antibody-antigen interaction was disrupted 
by pH change, using low-concentration acidic solution (5 mM 
HCl). The sensor signal was monitored to effectively return to 
baseline and new measurements were performed over approx-
imately 15 cycles before observing a significant decrease of 
the detection signal (62%) (Figure 4A). This reduction of the 
signal can be attributed to a loss of antibody recognition capa-
bility due to the repetitive exposure to acidic pH conditions, 
rather than affecting the polyA-Ab immobilization stability. In 
general, for both DNA probes and antibodies, the polyA-
biofunctionalization strategy showed a coefficient of variation 
(CV) between 3-12%, which is below the 15% maximum limit 
recommended for analytical methods.25 In addition to the sta-
bility and reproducibility studies, we briefly investigated the 
possibility to recycle the sensor surface in situ, that is, the 
capability of removing the immobilized probes, cleaning the 
sensor surface, and subsequently generating a new polyA layer 
with a new or different probe. Thereby, we could perform 
different assays on the same sensor surface without replace-
ment of the gold sensor chip, saving time and resources. To 
that end, we took advantage of the relatively weak interaction 
of adenine with gold compared to chemical binding. Strong 
acidic medium should break the hydrogen bonds as well as 
electrostatic interactions between adenine tail and the metal. In 
Figure 4B, we show the effect of 3M HCl solution in a polyA-
DNA functionalized biosensor. The strong acid solution is 
capable of almost completely remove the polyA-DNA layer 
within a few minutes. After, new in situ immobilization of 
polyA-DNA probe showed similar results to previous one, and 
we were able to hybridize a target sequence with practically 
the same efficiency. Although further improvement on the 
surface recycling should be done, these results open the oppor-
tunity for a faster and cost-effective operation of the biosensor, 
greatly reducing the number of sensor chips employed, con-
tributing to generate less environmental waste as well as the 
time of the analyses.  
 
Figure 4 Reproducibility and recycling assessment of the one-
step PolyA functionalization approach. (A) SPR sensorgram 
showing 16 detection cycles of CRP on a PolyA-Ab modified 
gold sensor chip. (B) SPR sensorgram showing two consecutive 
polyA-DNA immobilizations after the recycling of the gold sen-
sor surface with 3M HCl. 
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Figure 5. Assessment of the antifouling effect of the one-step 
polyA immobilization approach for serum 100%. (A) Nonspecific 
binding on the DNA-probe immobilization strategies; (B) Non-
specific binding on the antibody immobilization strategies. 
Antifouling test of the polyA based strategy. Finally, the 
fouling properties of this new immobilization approach were 
assessed. Serum is the most widely explored biofluid in clini-
cal analysis. In the blood stream, there are many circulating 
biomarkers like soluble proteins, DNA and RNA, whose de-
tection and precise quantification can inform about specific 
diseases or clinical conditions. However, direct evaluation of 
undiluted blood serum in SPR remains challenging and is still 
a not well-solved problem in direct label-free evaluation. The 
different molecules in serum matrix can interact with the sen-
sor surface producing high background signals that hinder the 
specific biosensor response from the protein and nucleic acid 
targets or lead to false positive results. Gold sensor surfaces 
coated with adenine oligos have proven to be resistant to non-
specific binding of unwanted nucleic acid adsorption and pro-
teins (i.e BSA) even at low densities due to the wide coverage 
area on behalf of the grafted polyA blocks (Figures 2B and 
3B). This characteristic could provide an advantage in obtain-
ing a suitable low-fouling monolayer for non-purified real 
sample analysis. To test our polyA-DNA and polyA-Ab mono-
layers, we compared their fouling resistance with SH-DNA, 
adsorbed antibodies, and alkanethiol SAMs. We flowed over 
the different monolayers a sample containing undiluted serum 
(serum 100%). As can be observed in Figure 5A, the DNA 
monolayer coated with polyA blocks presented a high re-
sistance to unwanted non-specific adsorptions from the matrix 
components of the serum sample (ΔR (%) = 2.4), showing a 
decrease in the background signal of 41% with regard to the 
surface coatings based on thiol-chemistry, either using SH-
DNA probes or MHDA/MUOH alkanethiols (ΔR (%) ~ 6). 
These results evidenced the great fouling properties provided 
by the polyA-DNA monolayer. Similar antifouling properties 
were obtained with the polyA-Ab monolayer (ΔR (%) = 3.5), 
minimizing the serum background signal by 52% and 20.5% 
compared to the antibody monolayers generated by physical 
adsorption and MHDA/MUOH, respectively (Figure 5B). 
Interestingly, the latter exhibited different fouling properties 
for DNA and antibody, showing less background signal in the 
antibody monolayer. This could be explained by the different 
electrostatic or hydrophobic forces of DNA and antibody with 
the soluble components of serum. Contrary, polyA-DNA 
monolayers showed higher fouling resistance than polyA-Ab 
ones. This phenomenon could be explained by the higher cov-
erage obtained by the polyA-DNA, which was further in-
creased by the combination of two polyA-lengths. Additional 
experiments need to be performed combining different polyA 
lengths conjugated with the antibody to maximize the gold 
sensor surface coverage. Overall, these results evidence the 
adequate anti-fouling properties provided by our one-step pol-
yA strategy for both, proteins and DNA.  
CONCLUSIONS 
Diagnostic tools offering a multimarker detection can accel-
erate the implementation of precision diagnostics in the clinic. 
The simultaneous analysis of biomarkers based on soluble 
proteins and nucleic acids will stimulate the creation of more 
accurate biomarker panels that can inform about the molecular 
condition of patients. While technological advances in optical 
biosensing have boosted record levels of sensitivity, there is 
still an unmet need for direct and accurate surface chemistry 
approaches that benefit both, nucleic acid and protein detec-
tion. We have presented an innovative methodology for the 
efficient functionalization of gold surfaces in one step that is 
equally beneficial for nucleic acid and protein-based detection 
assays. Our approach allows the direct, in situ immobilization 
of DNA probes and antibodies in a single step, showing sur-
face coverages comparable to the conventional multi-step 
methods. The methodology can accurately control the biore-
ceptor density, providing opportunities to generate biosensors 
that can detect analytes with more precision while avoiding 
steric hindrance repulsion forces. The results show excellent 
biosensor performances, obtaining competitive LODs for both, 
DNA and protein detection. We have demonstrated that the 
reproducibility of polyA biosensors can be maintained 
throughout 15-25 detection cycles with no loss in detection 
efficiency. Additionally, due to the non-covalent interaction of 
polyA-blocks with gold surfaces, we have proposed a surface 
recycling protocol, allowing the generation of a new biorecep-
tor monolayer without the need of the gold sensor chip re-
placement. This advantage places this strategy as a time and 
cost-effective methodology as well as environmentally friend-
ly. Finally, the antifouling properties were demonstrated by 
assessing the background signal produced by undiluted serum. 
Our results confirmed that polyA based monolayers can re-
duce the background signal produced by the presence of other 
molecules in the sample by up to 50% without the employ-
ment of additional blocking agents. Further optimization of the 
methodology by surfactant addition or PEG molecules may 
minimize the background signals close to the system noise. 
These results highlight the one-step polyA immobilization as 
an exceptional and straightforward functionalization strategy 
that could eventually be used for the development of multiana-
 8 
lyte biosensors for real sample evaluation, such as the so-
called liquid biopsies, opening the frontier for more informa-
tive and accurate diagnostic tests that can help in precision 
medicine approaches.  
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